← 產業報告目錄

Dental Soft-tissue Regeneration Market by Product Type (Autografts, Synthetic Biomaterials, Collagen-based Membranes), Application (Implantology, Periodontology), End User (Dental Hospitals, DSO's & Independent Clinics), Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-06-11頁數 227報告編號 MD9222

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The dental soft-tissue regeneration market is projected to grow from USD 0.38 billion in 2025 to USD 0.53 billion by 2030, at a CAGR of 6.8% during this period. This market has experienced significant growth due to several factors, including the rising incidence of periodontal diseases, increasing awareness of oral health, and the growing trend of cosmetic dentistry. Furthermore, initiatives to develop healthcare infrastructure in underdeveloped regions are driving the demand for more dental treatments and related products. Additionally, advancements in regenerative biomaterials have also played a crucial role in the market's expansion. “By product type, the collagen-based membranes segment accounted for the largest share of the dental soft-tissue regeneration market in 2024.” Based on product type, the collagen-based membranes segment is expected to dominate the dental soft-tissue regeneration market due to several factors. Collagen-based membranes act as barriers that guide tissue growth, supporting the healing of periodontal and implant-related defects. Additionally, these membranes can integrate with surrounding tissues and promote the growth of new connective tissue. Furthermore, innovations in regenerative biomaterials are also contributing to the growth of this market. “By application, the implantology segment accounted for the largest share of the dental soft-tissue regeneration market in 2024.” The implantology segment is expected to hold the largest share of the dental soft-tissue regeneration market due to factors such as the growing aging population, increased awareness of oral health, and rising demand for cosmetic dentistry. Products like collagen membranes, soft-tissue grafts, and advanced bioactive materials are increasingly utilized to promote healing in peri-implant soft tissues. Additionally, innovations in soft-tissue regenerative solutions and heightened awareness of dental aesthetics further contribute to the growth of the dental soft-tissue regeneration market. “By region, North America accounted for the largest share of the dental soft-tissue regeneration market.” Due to several factors, North America is expected to account for the largest share of the dental soft-tissue regeneration market during the forecast period. The region has advanced healthcare infrastructure and high healthcare expenditure rates, which drive the demand for sophisticated dental care treatments. Additionally, the significant increase in the geriatric population, who are more susceptible to periodontal diseases, accounts for a considerable portion of the treatments needed in North America. Favorable government policies, reimbursement frameworks for dental care treatments, and high patient insurance coverage further encourage access to advanced dental care. Moreover, ongoing research and development in dental technologies and biomaterials support the expansion of this market in the region. A breakdown of the primary participants (supply side) for the dental soft-tissue regeneration market referred to in this report is provided below: • By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%) • By Designation: C-level Executives (45%), Director-level Executives (35%), and Others (20%) • By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and the Middle East & Africa (10%) Prominent players in the dental soft-tissue regeneration market are Geistlich Pharma AG (Switzerland), DENTSPLY Sirona (US), Institut Straumann AG (Switzerland), Zimvie Inc. (US), Henry Schein, Inc. (US), AbbVie Inc. (US), Advanced Medical Solutions Group Plc (UK), Tissue Regenix (UK), Septodont Holding (France), Medical Consult Implants GmbH (Germany), Meccellis (US), Regedent Ag (Switzerland), Regenity (US), Envista (US), AD Surgical (US), LifeNet Health (US), B. & B. Dental S.R.L. (Italy), Alpha-Bio Tec. Ltd. (Israel), Lasak S.R.O. (Czechia), KeystoneDentalGroup (US), Neoss AG (Switzerland), BEGO GmbH Co. KG (Germany), Biotech Dental (France), Samyang Holdings Corporation (South Korea), and RTI Surgical (US). Research Coverage: The report examines the dental soft-tissue regeneration market and seeks to estimate its market size and future growth potential across various segments, including product type, application, end user, and region. Additionally, the report features a competitive analysis of the key players in this market, including their company profiles, service offerings, recent developments, and key market strategies. Reasons to Buy the Report This report is designed to assist both market leaders and new entrants in the dental soft-tissue regeneration market by providing close estimates of revenue figures. It will help stakeholders understand the competitive landscape, enabling them to better position their businesses and plan effective go-to-market strategies. Additionally, the report offers insights into the current trends in the market, including key drivers, restraints, challenges, and opportunities. This report provides insights into the following pointers:  Analysis of key drivers (rising prevalence of periodontal diseases, rising awareness and growing demand for cosmetic dentistry, advancements in biomaterials, and advancements in regenerative technology), restraints (inadequate reimbursement and high cost of dental services and dearth of trained dental practitioners), opportunities (consolidation of dental practices and rising DSO activity, growing focus on emerging economies and rising disposable income levels, and growing dental tourism in emerging countries), and challenges (pricing pressure faced by prominent market players, and stringent regulatory environment). • Market Penetration: It contains comprehensive information on products offered by the key players in the global dental soft-tissue regeneration market. The report covers various segments, including product type, application, end user, and region. • Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global dental soft-tissue regeneration market. • Market Development: Thorough knowledge and analysis of the profitable rising markets by type, application, end user, and region. • Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global dental soft-tissue regeneration market. • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global dental soft-tissue regeneration market.
目錄 Table of Contents
1 INTRODUCTION 23 1.1 STUDY OBJECTIVES 23 1.2 MARKET DEFINITION 23 1.3 STUDY SCOPE 24 1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD 24 1.3.2 INCLUSIONS & EXCLUSIONS 25 1.3.3 YEARS CONSIDERED 25 1.3.4 CURRENCY CONSIDERED 26 1.4 STAKEHOLDERS 26 2 RESEARCH METHODOLOGY 27 2.1 RESEARCH DATA 27 2.1.1 SECONDARY DATA 28 2.1.1.1 Key sources for secondary research 28 2.1.1.2 Key data from secondary sources 29 2.1.2 PRIMARY DATA 29 2.1.2.1 Objectives of primary research 30 2.1.2.2 Key data from primary sources 30 2.1.2.3 Key industry insights 31 2.1.2.4 Breakdown of primaries 31 2.2 MARKET SIZE ESTIMATION 33 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 33 2.2.2 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 34 2.2.3 TOP-DOWN APPROACH (SUPPLY-SIDE ANALYSIS) 36 2.3 DATA TRIANGULATION 39 2.4 MARKET SHARE ESTIMATION 40 2.5 STUDY ASSUMPTIONS 40 2.6 RESEARCH LIMITATIONS 41 2.7 RISK ANALYSIS 41 3 EXECUTIVE SUMMARY 42 4 PREMIUM INSIGHTS 45 4.1 DENTAL SOFT-TISSUE REGENERATION MARKET OVERVIEW 45 4.2 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE AND COUNTRY (2024) 46 4.3 DENTAL SOFT-TISSUE REGENERATION MARKET: REGIONAL MIX 47   4.4 DENTAL SOFT-TISSUE REGENERATION MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 47 4.5 DENTAL SOFT-TISSUE REGENERATION MARKET: EMERGING VS. DEVELOPED MARKETS 48 5 MARKET OVERVIEW 49 5.1 INTRODUCTION 49 5.2 MARKET DYNAMICS 49 5.2.1 DRIVERS 50 5.2.1.1 Rising prevalence of periodontal diseases 50 5.2.1.2 Growing demand for cosmetic dentistry 50 5.2.1.3 Rising popularity of biodegradable biomaterials 51 5.2.1.4 Advancements in regenerative technologies 51 5.2.2 RESTRAINTS 52 5.2.2.1 Inadequate dental insurance reimbursements and high cost of dental services 52 5.2.2.2 Dearth of trained dental practitioners 52 5.2.3 OPPORTUNITIES 53 5.2.3.1 Introduction of dental service organizations and consolidation of dental practices 53 5.2.3.2 Growth opportunities in emerging economies 53 5.2.3.3 Increasing popularity of dental tourism in emerging countries 53 5.2.4 CHALLENGES 54 5.2.4.1 Pricing pressure and increased market competition 54 5.2.4.2 Stringent regulatory environment 54 5.3 INDUSTRY TRENDS 55 5.3.1 ADVANCEMENTS IN DIGITAL DENTISTRY 55 5.3.2 INCREASED NUMBER OF MINIMALLY INVASIVE DENTAL PROCEDURES 55 5.4 VALUE CHAIN ANALYSIS 55 5.5 TECHNOLOGY ANALYSIS 57 5.5.1 KEY TECHNOLOGIES 57 5.5.1.1 3D bioprinting 57 5.5.2 COMPLEMENTARY TECHNOLOGIES 58 5.5.2.1 Laser-assisted technology 58 5.5.3 ADJACENT TECHNOLOGIES 58 5.5.3.1 Advanced biomaterials 58 5.6 PORTER’S FIVE FORCES ANALYSIS 59 5.6.1 THREAT OF NEW ENTRANTS 60 5.6.2 THREAT OF SUBSTITUTES 60 5.6.3 BARGAINING POWER OF SUPPLIERS 60 5.6.4 BARGAINING POWER OF BUYERS 60 5.6.5 INTENSITY OF COMPETITIVE RIVALRY 61   5.7 KEY STAKEHOLDERS & BUYING CRITERIA 61 5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS 61 5.7.2 KEY BUYING CRITERIA 62 5.8 REGULATORY ANALYSIS 62 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63 5.8.2 REGULATORY FRAMEWORK 65 5.8.2.1 North America 65 5.8.2.1.1 US 65 5.8.2.2 Europe 66 5.8.2.3 Asia Pacific 67 5.8.2.3.1 India 67 5.8.2.3.2 China 67 5.8.2.3.3 Japan 67 5.9 PATENT ANALYSIS 67 5.9.1 KEY PATENTS GRANTED 69 5.10 TRADE ANALYSIS 70 5.10.1 IMPORT DATA FOR HS CODE 300640 70 5.10.2 EXPORT DATA FOR HS CODE 300640 71 5.11 PRICING ANALYSIS 71 5.11.1 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY KEY PLAYER, 2022–2024 72 5.11.2 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY REGION, 2022–2024 73 5.12 KEY CONFERENCES & EVENTS, 2024–2025 73 5.13 UNMET NEEDS/END-USER EXPECTATIONS 75 5.14 ADJACENT MARKET ANALYSIS 76 5.15 ECOSYSTEM ANALYSIS 76 5.16 CASE STUDY ANALYSIS 78 5.16.1 GUIDED TISSUE REGENERATION BETWEEN NATURAL TOOTH AND IMPLANT WITH OSSIX PLUS 78 5.16.2 ENAMEL MATRIX DERIVATIVE FOR SOFT-TISSUE REGENERATION 79 5.16.3 APPLICATION OF HARD- AND SOFT-TISSUE REGENERATIVE APPROACH IN PREDICTABLE MANAGEMENT OF PERI-IMPLANTITIS 79 5.17 SUPPLY CHAIN ANALYSIS 80 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81 5.19 INVESTMENT & FUNDING SCENARIO 82 5.20 REIMBURSEMENT SCENARIO ANALYSIS 82 5.21 IMPACT OF AI/GEN AI ON DENTAL SOFT-TISSUE REGENERATION MARKET 83 5.22 PREVALENCE OF GINGIVAL DISEASES, BY KEY REGION, 2024 84 5.23 TOTAL NUMBER OF SURGERIES, BY KEY REGION, 2024 84   5.24 IMPACT OF 2025 US TARIFF ON DENTAL SOFT-TISSUE REGENERATION MARKET 84 5.24.1 INTRODUCTION 84 5.24.2 KEY TARIFF RATES 85 5.24.3 PRICE IMPACT ANALYSIS 86 5.24.4 IMPACT ON COUNTRY/REGION 86 5.24.4.1 North America 86 5.24.4.1.1 US 86 5.24.4.2 Europe 87 5.24.4.3 Asia Pacific 87 5.24.5 IMPACT ON END-USE INDUSTRIES 87 6 DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE 88 6.1 INTRODUCTION 89 6.2 COLLAGEN-BASED MEMBRANES 89 6.2.1 POTENTIAL TO ENHANCE DENTAL TISSUE REGENERATION TO DRIVE MARKET 89 6.3 AUTOGRAFTS 90 6.3.1 HIGH COMPATIBILITY AND REDUCED INFECTION RISKS TO DRIVE MARKET 90 6.4 SYNTHETIC BIOMATERIALS 92 6.4.1 TECHNOLOGICAL ADVANCEMENTS IN BIOMATERIALS TO FUEL MARKET GROWTH 92 6.5 OTHER PRODUCT TYPES 94 7 DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION 96 7.1 INTRODUCTION 97 7.2 IMPLANTOLOGY 97 7.2.1 GROWING NEED FOR IMPLANT-SUPPORTED SOFT-TISSUE REGENERATION TO DRIVE MARKET 97 7.3 PERIODONTOLOGY 98 7.3.1 INCREASING PREVALENCE OF PERIODONTAL DISEASES TO FAVOR MARKET GROWTH 98 7.4 OTHER APPLICATIONS 100 8 DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER 101 8.1 INTRODUCTION 102 8.2 DENTAL HOSPITALS 102 8.2.1 GROWING AWARENESS OF ORAL HEALTH TO BOOST MARKET 102 8.3 DSOS & INDEPENDENT CLINICS 104 8.3.1 ADVANCEMENTS IN DENTAL CARE TO DRIVE DEMAND 104 8.4 ACADEMIC & RESEARCH INSTITUTES 106 8.4.1 DEVELOPMENT OF ADVANCED DENTAL SOLUTIONS TO BOOST MARKET GROWTH 106   9 DENTAL SOFT-TISSUE REGENERATION MARKET, BY REGION 108 9.1 INTRODUCTION 109 9.2 NORTH AMERICA 110 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 110 9.2.2 US 113 9.2.2.1 US to dominate North American dental soft-tissue regeneration market 113 9.2.3 CANADA 115 9.2.3.1 Stringent regulatory compliance to support market growth 115 9.3 EUROPE 116 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 117 9.3.2 GERMANY 119 9.3.2.1 Germany accounted for the largest share of European dental soft-tissue regeneration market in 2024 119 9.3.3 UK 121 9.3.3.1 Rising number of geriatric patients to drive market 121 9.3.4 FRANCE 123 9.3.4.1 Well-established healthcare system to drive market 123 9.3.5 SPAIN 124 9.3.5.1 Favorable government initiatives for providing dental coverage to support market growth 124 9.3.6 ITALY 126 9.3.6.1 Increasing penetration of dental products to drive market growth 126 9.3.7 REST OF EUROPE 128 9.4 ASIA PACIFIC 129 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 129 9.4.2 JAPAN 132 9.4.2.1 Rising geriatric population to support market growth 132 9.4.3 CHINA 134 9.4.3.1 Growing geriatric population and increasing per capita income to support market growth 134 9.4.4 INDIA 135 9.4.4.1 Growing dental care sector to fuel market growth 135 9.4.5 AUSTRALIA 137 9.4.5.1 Growing healthcare expenditure to aid market growth 137 9.4.6 SOUTH KOREA 139 9.4.6.1 Well-developed healthcare sector to drive market 139 9.4.7 REST OF ASIA PACIFIC 140 9.5 LATIN AMERICA 142 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 142 9.5.2 BRAZIL 144 9.5.2.1 Brazil to hold largest share in Latin American market 144   9.5.3 MEXICO 145 9.5.3.1 Increasing healthcare infrastructure to propel market growth 145 9.5.4 ARGENTINA 147 9.5.4.1 Advancements in dental technology to spur growth 147 9.5.5 REST OF LATIN AMERICA 149 9.6 MIDDLE EAST & AFRICA 150 9.6.1 GOVERNMENT INITIATIVES FOR INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET GROWTH 150 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 150 9.7 GCC COUNTRIES 152 9.7.1 RISING DISPOSABLE INCOMES TO DRIVE MARKET GROWTH 152 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 152 10 COMPETITIVE LANDSCAPE 154 10.1 INTRODUCTION 154 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN 154 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DENTAL SOFT-TISSUE REGENERATION MARKET 155 10.3 REVENUE ANALYSIS, 2019–2023 156 10.4 MARKET SHARE ANALYSIS, 2024 156 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 159 10.5.1 STARS 159 10.5.2 EMERGING LEADERS 159 10.5.3 PERVASIVE PLAYERS 159 10.5.4 PARTICIPANTS 159 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 161 10.5.5.1 Company footprint 161 10.5.5.2 Region footprint 162 10.5.5.3 Product footprint 163 10.5.5.4 Application footprint 164 10.5.5.5 End-user footprint 165 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 166 10.6.1 PROGRESSIVE COMPANIES 166 10.6.2 RESPONSIVE COMPANIES 166 10.6.3 DYNAMIC COMPANIES 166 10.6.4 STARTING BLOCKS 166 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 168 10.6.5.1 Detailed list of key startups/SMEs 168 10.6.5.2 Competitive benchmarking of startups/SMEs, by product type 169 10.6.5.3 Competitive benchmarking of startups/SMEs, by region 169 10.7 BRAND/PRODUCT COMPARISON 170 10.8 R&D EXPENDITURE OF KEY PLAYERS 171   10.9 COMPANY VALUATION & FINANCIAL METRICS 171 10.9.1 FINANCIAL METRICS 171 10.9.2 COMPANY VALUATION 172 10.10 COMPETITIVE SCENARIO 172 10.10.1 PRODUCT LAUNCHES 172 10.10.2 DEALS 173 10.10.3 EXPANSIONS 174 11 COMPANY PROFILES 175 11.1 KEY PLAYERS 175 11.1.1 GEISTLICH PHARMA AG 175 11.1.1.1 Business overview 175 11.1.1.2 Products offered 175 11.1.1.3 Recent developments 176 11.1.1.3.1 Deals 176 11.1.1.3.2 Expansions 176 11.1.1.4 MnM view 176 11.1.1.4.1 Right to win 176 11.1.1.4.2 Strategic choices 176 11.1.1.4.3 Weaknesses & competitive threats 176 11.1.2 INSTITUT STRAUMANN AG 177 11.1.2.1 Business overview 177 11.1.2.2 Products offered 178 11.1.2.3 MnM view 179 11.1.2.3.1 Right to win 179 11.1.2.3.2 Strategic choices 179 11.1.2.3.3 Weaknesses & competitive threats 179 11.1.3 HENRY SCHEIN, INC. 180 11.1.3.1 Business overview 180 11.1.3.2 Products offered 181 11.1.3.3 Recent developments 182 11.1.3.3.1 Deals 182 11.1.3.4 MnM view 183 11.1.3.4.1 Right to win 183 11.1.3.4.2 Strategic choices 183 11.1.3.4.3 Weaknesses & competitive threats 183 11.1.4 ENVISTA 184 11.1.4.1 Business overview 184 11.1.4.2 Products offered 186 11.1.4.3 Recent developments 186 11.1.4.3.1 Deals 186   11.1.4.4 MnM view 187 11.1.4.4.1 Right to win 187 11.1.4.4.2 Strategic choices 187 11.1.4.4.3 Weaknesses & competitive threats 187 11.1.5 ZIMVIE INC. 188 11.1.5.1 Business overview 188 11.1.5.2 Products offered 189 11.1.5.3 Recent developments 190 11.1.5.3.1 Deals 190 11.1.5.4 MnM view 190 11.1.5.4.1 Right to win 190 11.1.5.4.2 Strategic choices 190 11.1.5.4.3 Weaknesses & competitive threats 190 11.1.6 DENTSPLY SIRONA INC. 191 11.1.6.1 Business overview 191 11.1.6.2 Products offered 192 11.1.6.3 Recent developments 193 11.1.6.3.1 Product launches 193 11.1.6.3.2 Deals 193 11.1.7 ABBVIE INC. 194 11.1.7.1 Business overview 194 11.1.7.2 Products offered 195 11.1.7.3 Recent developments 196 11.1.7.3.1 Expansions 196 11.1.8 ADVANCED MEDICAL SOLUTIONS GROUP PLC 197 11.1.8.1 Business overview 197 11.1.8.2 Products offered 198 11.1.8.3 Recent developments 199 11.1.8.3.1 Deals 199 11.1.9 TISSUE REGENIX 200 11.1.9.1 Business overview 200 11.1.9.2 Products offered 201 11.1.10 SEPTODONT HOLDING 202 11.1.10.1 Business overview 202 11.1.10.2 Products offered 202 11.1.10.3 Recent developments 202 11.1.10.3.1 Deals 202 11.1.11 MEDICAL CONSULT IMPLANTS GMBH 203 11.1.11.1 Business overview 203 11.1.11.2 Products offered 203   11.1.12 MECCELLIS BIOTECH 204 11.1.12.1 Business overview 204 11.1.12.2 Products offered 204 11.1.13 REGEDENT AG 205 11.1.13.1 Business overview 205 11.1.13.2 Products offered 205 11.1.14 REGENITY 206 11.1.14.1 Business overview 206 11.1.14.2 Products offered 206 11.1.14.3 Recent developments 207 11.1.14.3.1 Deals 207 11.1.15 AD SURGICAL 208 11.1.15.1 Business overview 208 11.1.15.2 Products offered 208 11.2 OTHER PLAYERS 209 11.2.1 LIFENET HEALTH 209 11.2.2 B. & B. DENTAL S.R.L. 210 11.2.3 ALPHA-BIO TEC. LTD. 211 11.2.4 LASAK S.R.O. 212 11.2.5 KEYSTONE DENTAL GROUP 213 11.2.6 NEOSS AG 214 11.2.7 BEGO GMBH & CO. KG 215 11.2.8 BIOTECH DENTAL 216 11.2.9 SAMYANG HOLDINGS CORPORATION 217 11.2.10 RTI SURGICAL 218 12 APPENDIX 219 12.1 DISCUSSION GUIDE 219 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 223 12.3 CUSTOMIZATION OPTIONS 225 12.4 RELATED REPORTS 225 12.5 AUTHOR DETAILS 226
圖表清單 List of Tables & Figures
TABLE 1 DENTAL SOFT-TISSUE REGENERATION MARKET: INCLUSIONS & EXCLUSIONS 25 TABLE 2 STANDARD CURRENCY CONVERSION RATES (USD), 2019–2023 26 TABLE 3 DENTAL SOFT-TISSUE REGENERATION MARKET: RISK ANALYSIS 41 TABLE 4 US: AVERAGE SPENDING BY PATIENTS ON COSMETIC DENTISTRY, 2021 VS. 2022 51 TABLE 5 DENTAL SOFT-TISSUE REGENERATION MARKET: PORTER’S FIVE FORCES 59 TABLE 6 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 61 TABLE 7 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 62 TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63 TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63 TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64 TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64 TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65 TABLE 13 DENTAL SOFT-TISSUE REGENERATION MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2022−2024 69 TABLE 14 IMPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019–2023 (USD THOUSAND) 70 TABLE 15 EXPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019–2023 (USD THOUSAND) 71 TABLE 16 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY KEY PLAYER, 2022–2024 (USD) 72 TABLE 17 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY REGION, 2022–2024 (USD) 73 TABLE 18 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY CONFERENCES & EVENTS, JANUARY 2024–DECEMBER 2025 74 TABLE 19 DENTAL SOFT-TISSUE REGENERATION MARKET: UNMET NEEDS/END-USER EXPECTATIONS 75 TABLE 20 DENTAL SOFT-TISSUE REGENERATION MARKET: ROLE IN ECOSYSTEM 77 TABLE 21 CASE STUDY 1: GUIDED TISSUE REGENERATION BETWEEN NATURAL TOOTH AND IMPLANT WITH OSSIX PLUS 78 TABLE 22 CASE STUDY 2: ENAMEL MATRIX DERIVATIVE FOR SOFT-TISSUE REGENERATION 79 TABLE 23 CASE STUDY 3: APPLICATION OF HARD- AND SOFT-TISSUE REGENERATIVE APPROACH IN PREDICTABLE MANAGEMENT OF PERI-IMPLANTITIS 79 TABLE 24 PREVALENCE OF GINGIVAL DISEASES BY KEY REGION 2024 84 TABLE 25 TOTAL NUMBER OF SURGERIES BY KEY REGION 2024 84 TABLE 26 US ADJUSTED RECIPROCAL TARIFF RATES 85 TABLE 27 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR DENTAL SOFT-TISSUE REGENERATION 86 TABLE 28 DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 89 TABLE 29 DENTAL SOFT-TISSUE REGENERATION MARKET FOR COLLAGEN-BASED MEMBRANES, BY COUNTRY, 2023–2030 (USD MILLION) 90 TABLE 30 DENTAL SOFT-TISSUE REGENERATION MARKET FOR AUTOGRAFTS, BY COUNTRY, 2023–2030 (USD MILLION) 91 TABLE 31 DENTAL SOFT-TISSUE REGENERATION MARKET FOR SYNTHETIC BIOMATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 93 TABLE 32 DENTAL SOFT-TISSUE REGENERATION MARKET FOR OTHER PRODUCT TYPES, BY COUNTRY, 2023–2030 (USD MILLION) 95 TABLE 33 DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 97 TABLE 34 DENTAL SOFT-TISSUE REGENERATION MARKET FOR IMPLANTOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 98 TABLE 35 DENTAL SOFT-TISSUE REGENERATION MARKET FOR PERIODONTOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 36 DENTAL SOFT-TISSUE REGENERATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 37 DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 102 TABLE 38 DENTAL SOFT-TISSUE REGENERATION MARKET FOR DENTAL HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 39 DENTAL SOFT-TISSUE REGENERATION FOR DSOS & INDEPENDENT CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 40 DENTAL SOFT-TISSUE REGENERATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 41 DENTAL SOFT-TISSUE REGENERATION MARKET, BY REGION, 2023–2030 (USD MILLION) 110 TABLE 42 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 43 NORTH AMERICA, DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 112 TABLE 44 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 112 TABLE 45 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 112 TABLE 46 US: KEY MACROINDICATORS 113 TABLE 47 US: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 114 TABLE 48 US: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 114 TABLE 49 US: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 114 TABLE 50 CANADA: KEY MACROINDICATORS 115 TABLE 51 CANADA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 115 TABLE 52 CANADA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 116 TABLE 53 CANADA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 116 TABLE 54 EUROPE DENTAL SOFT-TISSUE REGENERATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 55 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 118 TABLE 56 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 118 TABLE 57 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 119 TABLE 58 GERMANY: KEY MACROINDICATORS 120 TABLE 59 GERMANY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 120 TABLE 60 GERMANY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 120 TABLE 61 GERMANY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 121 TABLE 62 UK: KEY MACROINDICATORS 121 TABLE 63 UK: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 122 TABLE 64 UK: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 122 TABLE 65 UK: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 122 TABLE 66 FRANCE: KEY MACROINDICATORS 123 TABLE 67 FRANCE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 123 TABLE 68 FRANCE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 124 TABLE 69 FRANCE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 124 TABLE 70 SPAIN: KEY MACROINDICATORS 125 TABLE 71 SPAIN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 125 TABLE 72 SPAIN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 125 TABLE 73 SPAIN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 126 TABLE 74 ITALY: KEY MACROINDICATORS 126 TABLE 75 ITALY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 127 TABLE 76 ITALY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 127 TABLE 77 ITALY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 127 TABLE 78 REST OF EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 128 TABLE 79 REST OF EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 128 TABLE 80 REST OF EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 129 TABLE 81 ASIA PACIFIC DENTAL SOFT-TISSUE REGENERATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 82 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 131 TABLE 83 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 131 TABLE 84 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 132 TABLE 85 JAPAN: KEY MACROINDICATORS 132 TABLE 86 JAPAN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 133 TABLE 87 JAPAN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 133 TABLE 88 JAPAN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 133 TABLE 89 CHINA: KEY MACROINDICATORS 134 TABLE 90 CHINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 134 TABLE 91 CHINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 135 TABLE 92 CHINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 135 TABLE 93 INDIA: KEY MACROINDICATORS 136 TABLE 94 INDIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 136 TABLE 95 INDIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 136 TABLE 96 INDIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 137 TABLE 97 AUSTRALIA: KEY MACROINDICATORS 137 TABLE 98 AUSTRALIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 138 TABLE 99 AUSTRALIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 138 TABLE 100 AUSTRALIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 138 TABLE 101 SOUTH KOREA: KEY MACROINDICATORS 139 TABLE 102 SOUTH KOREA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 139 TABLE 103 SOUTH KOREA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 140 TABLE 104 SOUTH KOREA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 140 TABLE 105 REST OF ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 141 TABLE 106 REST OF ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 141 TABLE 107 REST OF ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 141 TABLE 108 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 109 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 143   TABLE 110 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 143 TABLE 111 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 143 TABLE 112 BRAZIL: KEY MACROINDICATORS 144 TABLE 113 BRAZIL: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 144 TABLE 114 BRAZIL: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 145 TABLE 115 BRAZIL: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 145 TABLE 116 MEXICO: KEY MACROINDICATORS 146 TABLE 117 MEXICO: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 146 TABLE 118 MEXICO: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 146 TABLE 119 MEXICO: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 147 TABLE 120 ARGENTINA: KEY MACROINDICATORS 147 TABLE 121 ARGENTINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 148 TABLE 122 ARGENTINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 148 TABLE 123 ARGENTINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 148 TABLE 124 REST OF LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 149 TABLE 125 REST OF LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 149 TABLE 126 REST OF LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 150 TABLE 127 MIDDLE EAST & AFRICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 151 TABLE 128 MIDDLE EAST & AFRICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 151 TABLE 129 MIDDLE EAST & AFRICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 151 TABLE 130 GCC COUNTRIES: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 152 TABLE 131 GCC COUNTRIES: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 153 TABLE 132 GCC COUNTRIES: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 153 TABLE 133 DENTAL SOFT-TISSUE REGENERATION MARKET: DEGREE OF COMPETITION 157 TABLE 134 DENTAL SOFT-TISSUE REGENERATION MARKET: REGION FOOTPRINT 162 TABLE 135 DENTAL SOFT-TISSUE REGENERATION MARKET: PRODUCT FOOTPRINT 163 TABLE 136 DENTAL SOFT-TISSUE REGENERATION MARKET: APPLICATION FOOTPRINT 164 TABLE 137 DENTAL SOFT-TISSUE REGENERATION MARKET: END-USER FOOTPRINT 165 TABLE 138 DENTAL SOFT-TISSUE REGENERATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES 168 TABLE 139 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY PRODUCT TYPE 169 TABLE 140 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION 169 TABLE 141 DENTAL SOFT-TISSUE REGENERATION MARKET: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2025 172 TABLE 142 DENTAL SOFT-TISSUE REGENERATION MARKET: DEALS, JANUARY 2021–MARCH 2025 173 TABLE 143 DENTAL SOFT-TISSUE REGENERATION MARKET: EXPANSIONS, JANUARY 2021–MARCH 2025 174 TABLE 144 GEISTLICH PHARMA AG: COMPANY OVERVIEW 175 TABLE 145 GEISTLICH PHARMA AG: PRODUCTS OFFERED 175 TABLE 146 GEISTLICH PHARMA AG: DEALS, JANUARY 2021–MARCH 2025 176 TABLE 147 GEISTLICH PHARMA AG: EXPANSIONS, JANUARY 2021–MARCH 2025 176 TABLE 148 INSTITUT STRAUMANN AG: COMPANY OVERVIEW 177 TABLE 149 INSTITUT STRAUMANN AG: PRODUCTS OFFERED 178 TABLE 150 HENRY SCHEIN, INC.: COMPANY OVERVIEW 180 TABLE 151 HENRY SCHEIN, INC.: PRODUCTS OFFERED 181 TABLE 152 HENRY SCHEIN, INC.: DEALS, JANUARY 2021–MARCH 2025 182 TABLE 153 ENVISTA: COMPANY OVERVIEW 184 TABLE 154 ENVISTA: PRODUCTS OFFERED 186 TABLE 155 ENVISTA: DEALS, JANUARY 2021–MARCH 2025 186 TABLE 156 ZIMVIE INC.: COMPANY OVERVIEW 188 TABLE 157 ZIMVIE INC.: PRODUCTS OFFERED 189 TABLE 158 ZIMVIE INC.: DEALS, JANUARY 2021–MARCH 2025 190 TABLE 159 DENTSPLY SIRONA INC.: COMPANY OVERVIEW 191 TABLE 160 DENTSPLY SIRONA INC.: PRODUCTS OFFERED 192 TABLE 161 DENTSPLY SIRONA INC.: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2025 193 TABLE 162 DENTSPLY SIRONA INC.: DEALS, JANUARY 2021–MARCH 2025 193 TABLE 163 ABBVIE INC.: COMPANY OVERVIEW 194 TABLE 164 ABBVIE INC.: PRODUCTS OFFERED 195 TABLE 165 ABBVIE INC.: EXPANSIONS, JANUARY 2021–MARCH 2025 196 TABLE 166 ADVANCED MEDICAL SOLUTIONS GROUP PLC: COMPANY OVERVIEW 197 TABLE 167 ADVANCED MEDICAL SOLUTIONS GROUP PLC: PRODUCTS OFFERED 198 TABLE 168 ADVANCED MEDICAL SOLUTIONS GROUP PLC: DEALS, JANUARY 2021–MARCH 2025 199 TABLE 169 TISSUE REGENIX: COMPANY OVERVIEW 200 TABLE 170 TISSUE REGENIX: PRODUCTS OFFERED 201 TABLE 171 SEPTODONT HOLDING: COMPANY OVERVIEW 202 TABLE 172 SEPTODONT HOLDING: PRODUCTS OFFERED 202 TABLE 173 SEPTODONT HOLDING: DEALS, JANUARY 2021–MARCH 2025 202 TABLE 174 MEDICAL CONSULT IMPLANTS GMBH: COMPANY OVERVIEW 203 TABLE 175 MEDICAL CONSULT IMPLANTS GMBH: PRODUCTS OFFERED 203   TABLE 176 MECCELLIS BIOTECH: COMPANY OVERVIEW 204 TABLE 177 MECCELLIS BIOTECH: PRODUCTS OFFERED 204 TABLE 178 REGEDENT AG: COMPANY OVERVIEW 205 TABLE 179 REGEDENT AG: PRODUCTS OFFERED 205 TABLE 180 REGENITY: COMPANY OVERVIEW 206 TABLE 181 REGENITY: PRODUCTS OFFERED 206 TABLE 182 REGENITY: DEALS, JANUARY 2021–MARCH 2025 207 TABLE 183 AD SURGICAL: COMPANY OVERVIEW 208 TABLE 184 AD SURGICAL: PRODUCTS OFFERED 208 TABLE 185 LIFENET HEALTH: COMPANY OVERVIEW 209 TABLE 186 B. & B. DENTAL S.R.L.: COMPANY OVERVIEW 210 TABLE 187 ALPHA-BIO TEC. LTD.: COMPANY OVERVIEW 211 TABLE 188 LASAK S.R.O.: COMPANY OVERVIEW 212 TABLE 189 KEYSTONE DENTAL GROUP: COMPANY OVERVIEW 213 TABLE 190 NEOSS AG: COMPANY OVERVIEW 214 TABLE 191 BEGO GMBH & CO. KG: COMPANY OVERVIEW 215 TABLE 192 BIOTECH DENTAL: COMPANY OVERVIEW 216 TABLE 193 SAMYANG HOLDINGS CORPORATION: COMPANY OVERVIEW 217 TABLE 194 RTI SURGICAL: COMPANY OVERVIEW 218 FIGURE 1 DENTAL SOFT-TISSUE REGENERATION MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD 24 FIGURE 2 DENTAL SOFT-TISSUE REGENERATION MARKET: YEARS CONSIDERED 25 FIGURE 3 DENTAL SOFT-TISSUE REGENERATION MARKET: RESEARCH DESIGN 27 FIGURE 4 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY DATA FROM SECONDARY SOURCES 29 FIGURE 5 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY PRIMARY SOURCES 29 FIGURE 6 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY DATA FROM PRIMARY SOURCES 30 FIGURE 7 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY INDUSTRY INSIGHTS 31 FIGURE 8 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 31 FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 32 FIGURE 10 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 32 FIGURE 11 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 33 FIGURE 12 REVENUE SHARE ANALYSIS ILLUSTRATION FOR INSTITUT STRAUMANN AG (2024) 34 FIGURE 13 SUPPLY-SIDE MARKET SIZE ESTIMATION: DENTAL SOFT-TISSUE REGENERATION MARKET (2023) 35 FIGURE 14 DENTAL SOFT-TISSUE REGENERATION MARKET: TOP-DOWN APPROACH 36 FIGURE 15 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 37 FIGURE 16 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38 FIGURE 17 DENTAL SOFT-TISSUE REGENERATION MARKET: DATA TRIANGULATION 39 FIGURE 18 DENTAL SOFT-TISSUE REGENERATION MARKET: STUDY ASSUMPTIONS 40 FIGURE 19 DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION) 42 FIGURE 20 DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 43 FIGURE 21 DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 43 FIGURE 22 DENTAL SOFT-TISSUE REGENERATION MARKET: REGIONAL SNAPSHOT 44 FIGURE 23 RISING PREVALENCE OF PERIODONTAL DISEASES AND GROWING FOCUS ON DENTAL TOURISM IN EMERGING ECONOMIES TO DRIVE MARKET 45 FIGURE 24 REST OF ASIA PACIFIC AND COLLAGEN-BASED MEMBRANES COMMANDED LARGEST MARKET SHARE IN 2024 46 FIGURE 25 ASIA PACIFIC TO DOMINATE MARKET FROM 2025 TO 2030 47 FIGURE 26 CHINA TO GROW AT HIGHEST CAGR DURING STUDY PERIOD 47 FIGURE 27 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 48 FIGURE 28 DENTAL SOFT-TISSUE REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49 FIGURE 29 DENTAL SOFT-TISSUE REGENERATION MARKET: VALUE CHAIN ANALYSIS 56 FIGURE 30 DENTAL SOFT-TISSUE REGENERATION MARKET: PORTER’S FIVE FORCES ANALYSIS 59 FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 61 FIGURE 32 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 62 FIGURE 33 NUMBER OF PATENT PUBLISHED (JANUARY 2014–NOVEMBER 2024) 68 FIGURE 34 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DENTAL SOFT-TISSUE REGENERATION (JANUARY 2014– NOVEMBER 2024) 68 FIGURE 35 TOP PATENT APPLICANTS, BY JURISDICTION, JANUARY 2014−NOVEMBER 2024 69 FIGURE 36 DENTAL SOFT-TISSUE REGENERATION MARKET: ADJACENT MARKETS 76 FIGURE 37 DENTAL SOFT-TISSUE REGENERATION MARKET: ECOSYSTEM ANALYSIS 77 FIGURE 38 DENTAL SOFT-TISSUE REGENERATION MARKET: SUPPLY CHAIN ANALYSIS 80 FIGURE 39 DENTAL SOFT-TISSUE REGENERATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81 FIGURE 40 DENTAL SOFT-TISSUE REGENERATION MARKET: FUNDING AND NUMBER OF DEALS, 2020–2023 82 FIGURE 41 DENTAL SOFT-TISSUE REGENERATION MARKET: IMPACT OF AI/GEN AI 83 FIGURE 42 DENTAL SOFT-TISSUE REGENERATION MARKET: GEOGRAPHIC SNAPSHOT 109 FIGURE 43 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET SNAPSHOT 111 FIGURE 44 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET SNAPSHOT 117 FIGURE 45 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET SNAPSHOT 130 FIGURE 46 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN DENTAL SOFT-TISSUE REGENERATION MARKET 155 FIGURE 47 REVENUE ANALYSIS OF KEY PLAYERS IN DENTAL SOFT-TISSUE REGENERATION MARKET (2019–2023) 156 FIGURE 48 MARKET SHARE ANALYSIS OF KEY PLAYERS IN DENTAL SOFT-TISSUE REGENERATION MARKET (2024) 157 FIGURE 49 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 160 FIGURE 50 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPANY FOOTPRINT 161 FIGURE 51 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 167 FIGURE 52 DENTAL SOFT-TISSUE REGENERATION MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 170 FIGURE 53 R&D EXPENDITURE OF KEY PLAYERS, 2022 VS. 2023 171 FIGURE 54 EV/EBITDA OF KEY VENDORS 171 FIGURE 55 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 172 FIGURE 56 INSTITUT STRAUMANN AG: COMPANY SNAPSHOT 178 FIGURE 57 HENRY SCHEIN, INC.: COMPANY SNAPSHOT 181 FIGURE 58 ENVISTA: COMPANY SNAPSHOT 185 FIGURE 59 ZIMVIE INC.: COMPANY SNAPSHOT 189 FIGURE 60 DENTSPLY SIRONA INC.: COMPANY SNAPSHOT 192 FIGURE 61 ABBVIE INC.: COMPANY SNAPSHOT 195 FIGURE 62 ADVANCED MEDICAL SOLUTIONS GROUP PLC: COMPANY SNAPSHOT 198 FIGURE 63 TISSUE REGENIX: COMPANY SNAPSHOT 201

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們